These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7750805

  • 41. The effect of in vivo glutathione depletion with buthionine sulfoximine on rat embryo development.
    Hales BF, Brown H.
    Teratology; 1991 Sep; 44(3):251-7. PubMed ID: 1948763
    [Abstract] [Full Text] [Related]

  • 42. Influence of intracellular glutathione concentration of lipofuscin accumulation in cultured neonatal rat cardiac myocytes.
    Gao G, Ollinger K, Brunk UT.
    Free Radic Biol Med; 1994 Feb; 16(2):187-94. PubMed ID: 7911777
    [Abstract] [Full Text] [Related]

  • 43. Modulation of rat erythrocyte antioxidant defense system by buthionine sulfoximine and its reversal by glutathione monoester therapy.
    Rajasekaran NS, Devaraj NS, Devaraj H.
    Biochim Biophys Acta; 2004 Mar 02; 1688(2):121-9. PubMed ID: 14990342
    [Abstract] [Full Text] [Related]

  • 44. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 02; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 45. Effects of buthionine sulfoximine (BSO) on mercury distribution after Hg(o) exposure.
    Kim CY, Watanabe C, Satoh H.
    Toxicology; 1995 Apr 12; 98(1-3):67-72. PubMed ID: 7740555
    [Abstract] [Full Text] [Related]

  • 46. Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines.
    Leung SW, Mitchell JB, al-Nabulsi I, Friedman N, Newsome J, Belldegrun A, Kasid U.
    Cancer; 1993 Apr 01; 71(7):2276-85. PubMed ID: 8095848
    [Abstract] [Full Text] [Related]

  • 47. Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoximine.
    Torres VE, Bengal RJ, Litwiller RD, Wilson DM.
    J Am Soc Nephrol; 1997 Aug 01; 8(8):1283-91. PubMed ID: 9259355
    [Abstract] [Full Text] [Related]

  • 48. Use of the inhibition of enzymatic antioxidant systems in order to evaluate their physiological importance.
    Michiels C, Remacle J.
    Eur J Biochem; 1988 Nov 01; 177(2):435-41. PubMed ID: 2903826
    [Abstract] [Full Text] [Related]

  • 49. Conditions for maximizing and inhibiting synthesis of glutathione in cultured rat lenses: an application of HPLC with radioisotope detection.
    Murray DL, Rathbun WB.
    Curr Eye Res; 1990 Jan 01; 9(1):55-63. PubMed ID: 1968828
    [Abstract] [Full Text] [Related]

  • 50. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R, Miners JO.
    Biochem Pharmacol; 1984 Oct 01; 33(19):2989-94. PubMed ID: 6148944
    [Abstract] [Full Text] [Related]

  • 51. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y, Yoshida O.
    Cancer; 1994 Feb 01; 73(3):730-7. PubMed ID: 8299097
    [Abstract] [Full Text] [Related]

  • 52. Modifications in lens protein biosynthesis signal the initiation of cataracts induced by buthionine sulfoximine in mice.
    Calvin HI, Wu JX, Viswanadhan K, Fu SC.
    Exp Eye Res; 1996 Oct 01; 63(4):357-68. PubMed ID: 8944543
    [Abstract] [Full Text] [Related]

  • 53. Anticataractogenic property of gamma-glutamylcysteine ethyl ester in an animal model of cataract.
    Ohtsu A, Kitahara S, Fujii K.
    Ophthalmic Res; 1991 Oct 01; 23(1):51-8. PubMed ID: 1870842
    [Abstract] [Full Text] [Related]

  • 54. Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice.
    Mårtensson J, Meister A.
    Proc Natl Acad Sci U S A; 1992 Dec 01; 89(23):11566-8. PubMed ID: 1454849
    [Abstract] [Full Text] [Related]

  • 55. Interaction of buthionine sulfoximine and the stabilization of DNA-topoisomerase II complexes by doxorubicin.
    Bonner JA, Christianson TJ, Lawrence TS.
    Int J Radiat Oncol Biol Phys; 1992 Dec 01; 22(3):519-23. PubMed ID: 1310496
    [Abstract] [Full Text] [Related]

  • 56. Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
    Mayer RD, Lee KE, Cockett AT.
    Cancer Chemother Pharmacol; 1987 Dec 01; 20(3):207-10. PubMed ID: 2890443
    [Abstract] [Full Text] [Related]

  • 57. Glutathione biosynthesis and its inhibition.
    Meister A.
    Methods Enzymol; 1995 Dec 01; 252():26-30. PubMed ID: 7476360
    [No Abstract] [Full Text] [Related]

  • 58. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V, Boyd MR.
    Biochem Pharmacol; 1991 May 01; 41(9):1311-8. PubMed ID: 2018563
    [Abstract] [Full Text] [Related]

  • 59. Glutathione, a first line of defense against cadmium toxicity.
    Singhal RK, Anderson ME, Meister A.
    FASEB J; 1987 Sep 01; 1(3):220-3. PubMed ID: 2887478
    [Abstract] [Full Text] [Related]

  • 60. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2'-deoxyguanosine in red blood cells.
    Misra M, Alcedo JA, Wetterhahn KE.
    Carcinogenesis; 1994 Dec 01; 15(12):2911-7. PubMed ID: 8001255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.